Headquarters Maharashtra | Industry Pharmaceuticals Area served Global Revenue 1.2 billion USD Founded 1977 | |
 | ||
Traded as BSE: 532296NSE: GLENMARK) Key people Glenn Saldanha, MD & Chairman Stock price GLENMARK (NSE) ₹ 888.60 +9.65 (+1.10%)14 Mar, 3:30 PM IST - Disclaimer CEO Glenn Mario Saldanha (2001–) Subsidiaries Glenmark Pharmaceuticals (Australia) Pty.Ltd | ||
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It is a research driven global pharmaceutical organization focused on discovering novel molecules and developing high-quality generics and specialty products for markets across the globe.
Glenmark has 17 manufacturing facilities across 5 countries including US, Argentina, Czech Republic and India. Glenmark has 5 R&D centers around the world engaged in discovery of novel biological and chemical entities.
References
Glenmark Pharmaceuticals Wikipedia(Text) CC BY-SA